Language:
  
[Sign in] [Register]   

EIAab logo

Index > Protein center > CYBB(Gene name) > Human
  • Add your favorite
  • CYBB (Gene name),
  • Cytochrome b-245 heavy chain (Protein name ),  CY24B_HUMAN from NCBI database.
  • top
  • Come back to page head.
  • |
  • General Annotation
  • |
  • Antigen Annotation
  • |
  • 3D
  • |
  • Predicted Eptitope
  • |
  • Vaild Sequence
  • |
  • Related Databases
  • |
  • Feedback
  • Gene name:
    CYBB(NOX2);
    Protein name:
    Cytochrome b-245 heavy chain;
    Alternative:
    Cytochrome b(558) subunit beta(Cytochrome b558 subunit beta);CGD91-phox;NADPH oxidase 2;Heme-binding membrane glycoprotein gp91phox;Superoxide-generating NADPH oxidase heavy chain subunit;Neutrophil cytochrome b 91 kDa polypeptide;gp91-phox;gp91-1;p22 phagocyte B-cytochrome;
    Organism:
    Human (Homo sapiens). 
    General Annotation
    Sub Unit:
    Composed of a heavy chain (beta) and a light chain (alpha).
    Function:
    Critical component of the membrane-bound oxidase of phagocytes that generates superoxide. It is the terminal component of a respiratory chain that transfers single electrons from cytoplasmic NADPH across the plasma membrane to molecular oxygen on the exterior. Also functions as a voltage-gated proton channel that mediates the H(+) currents of resting phagocytes. It participates in the regulation of cellular pH and is blocked by zinc.
    Subcellular Location:
    Membrane Multi-pass membrane protein
    Protein Attributes:
    Sequence length:
    570
    Sequence:
    50:
    MGNWAVNEGL | SIFVILVWLG | LNVFLFVWYY | RVYDIPPKFF | YTRKLLGSAL | 
    100:
    ALARAPAACL | NFNCMLILLP | VCRNLLSFLR | GSSACCSTRV | RRQLDRNLTF | 
    150:
    HKMVAWMIAL | HSAIHTIAHL | FNVEWCVNAR | VNNSDPYSVA | LSELGDRQNE | 
    200:
    SYLNFARKRI | KNPEGGLYLA | VTLLAGITGV | VITLCLILII | TSSTKTIRRS | 
    250:
    YFEVFWYTHH | LFVIFFIGLA | IHGAERIVRG | QTAESLAVHN | ITVCEQKISE | 
    300:
    WGKIKECPIP | QFAGNPPMTW | KWIVGPMFLY | LCERLVRFWR | SQQKVVITKV | 
    350:
    VTHPFKTIEL | QMKKKGFKME | VGQYIFVKCP | KVSKLEWHPF | TLTSAPEEDF | 
    400:
    FSIHIRIVGD | WTEGLFNACG | CDKQEFQDAW | KLPKIAVDGP | FGTASEDVFS | 
    450:
    YEVVMLVGAG | IGVTPFASIL | KSVWYKYCNN | ATNLKLKKIY | FYWLCRDTHA | 
    500:
    FEWFADLLQL | LESQMQERNN | AGFLSYNIYL | TGWDESQANH | FAVHHDEEKD | 
    550:
    VITGLKQKTL | YGRPNWDNEF | KTIASQHPNT | RIGVFLCGPE | ALAETLSKQS | 
    570:
    ISNSESGPRG | VHFIFNKENF | 
    3D Structure:
    N/A
    Predicted Eptitope:
    Please Sign in.
    EIAab Sequence  Vaild Sequence:
    Please Sign in.
    Related Databases
    KEGG:
    UniGene:
    SMR:
    String:
    Pfam:
    MIM:
    Uniprot:
     
    FOR
    ELISA Kit for Human Cytochrome b-245 heavy chain
    Cat.:
    E10150h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human Cytochrome b-245 heavy chain
    Cat.:
    E10150m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human Cytochrome b-245 heavy chain
    Cat.:
    E10150b
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    ELISA Kit for Human Cytochrome b-245 heavy chain
    Cat.:
    E10150p
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human Cytochrome b-245 heavy chain
    Cat.:
    U10150b
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human Cytochrome b-245 heavy chain
    Cat.:
    U10150p
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human Cytochrome b-245 heavy chain
    Cat.:
    U10150m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human Cytochrome b-245 heavy chain
    Cat.:
    U10150h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Polyclonal Antibody for Human Cytochrome b-245 heavy chain
    Cat.:
    P10150Rb-m
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Polyclonal Antibody for Human Cytochrome b-245 heavy chain
    Polyclonal Antibody for Human Cytochrome b-245 heavy chain
    Polyclonal Antibody for Human Cytochrome b-245 heavy chain
    Cat.:
    P10150Rb-h
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Monoclonal Antibody for Human Cytochrome b-245 heavy chain
    Monoclonal Antibody for Human Cytochrome b-245 heavy chain
    Monoclonal Antibody for Human Cytochrome b-245 heavy chain
    Monoclonal Antibody for Human Cytochrome b-245 heavy chain
    Protein for Human Cytochrome b-245 heavy chain
    Protein for Human Cytochrome b-245 heavy chain
    Protein for Human Cytochrome b-245 heavy chain
    Protein for Human Cytochrome b-245 heavy chain

    R&D Technical Data
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Precision
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Recovery
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Linearity
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    References
    1. 1.
      "Cloning the gene for an inherited human disorder -- chronic granulomatous disease -- on the basis of its chromosomal location."
      Royer-Pokora B. , Kunkel L.M. , Monaco A.P. , Goff S.C. , Newburger P.E. , Baehner R.L. , Cole F.S. , Curnutte J.T. , Orkin S.H.
      Nature322:32-38(1986) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA]
    2. 2.
      "CYBB mutation analysis in X-linked chronic granulomatous disease."
      Jirapongsananuruk O. , Niemela J.E. , Malech H.L. , Fleisher T.A.
      Clin. Immunol.104:73-76(2002) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA];VARIANTS CGD ASP-41 AND ARG-537;VARIANTS ARG-364 AND GLU-517
    3. 3.
      NHLBI resequencing and genotyping service (RS&G)
      Submitted (2005-12) to the EMBL/GenBank/DDBJ databases
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]
    4. 4.
      "Complete sequencing and characterization of 21,243 full-length human cDNAs."
      Ota T. , Suzuki Y. , Nishikawa T. , Otsuki T. , Sugiyama T. , Irie R. , Wakamatsu A. , Hayashi K. , Sato H. , Nagai K. , Kimura K. , Makita H. , Sekine M. , Obayashi M. , Nishi T. , Shibahara T. , Tanaka T. , Ishii S. , more...
      Nat. Genet.36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]
      tissue: Brain.
    5. 5.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
    6. 6.
      "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
      The MGC Project Team
      Genome Res.14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]
      tissue: Lymph.
    7. 7.
      "The glycoprotein encoded by the X-linked chronic granulomatous disease locus is a component of the neutrophil cytochrome b complex."
      Dinauer M.C. , Orkin S.H. , Brown R. , Jesaitis A.J. , Parkos C.A.
      Nature327:717-720(1987) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-135
    8. 8.
      "Nonhomologous recombination between the cytochrome b558 heavy chain gene (CYBB) and LINE-1 causes an X-linked chronic granulomatous disease."
      Kumatori A. , Faizunnessa N.N. , Suzuki S. , Moriuchi T. , Kurozumi H. , Nakamura M.
      Genomics53:123-128(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 233-267
      tissue: Peripheral blood.
    9. 9.
      "The X-linked chronic granulomatous disease gene codes for the beta-chain of cytochrome b-245."
      Teahan C. , Rowe P. , Parker P. , Totty N. , Segal A.W.
      Nature327:720-721(1987) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PROTEIN SEQUENCE OF 2-44;SUBUNIT
    10. 10.
      "Evidence that the product of the human X-linked CGD gene, gp91-phox, is a voltage-gated H(+) pathway."
      Henderson L.M. , Meech R.W.
      J. Gen. Physiol.114:771-786(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: CHARACTERIZATION AS A PROTON CHANNEL
    11. 11.
      "Regulation of the phagocyte NADPH oxidase activity: phosphorylation of gp91phox/NOX2 by protein kinase C enhances its diaphorase activity and binding to Rac2, p67phox, and p47phox."
      Raad H. , Paclet M.H. , Boussetta T. , Kroviarski Y. , Morel F. , Quinn M.T. , Gougerot-Pocidalo M.A. , Dang P.M. , El-Benna J.
      FASEB J.23:1011-1022(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: SUBUNIT;PHOSPHORYLATION;TISSUE SPECIFICITY
    12. 12.
      "Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry."
      Chen R. , Jiang X. , Sun D. , Han G. , Wang F. , Ye M. , Wang L. , Zou H.
      J. Proteome Res.8:651-661(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-132; ASN-149 AND ASN-240
      tissue: Liver.
    13. 13.
      "Interaction of human neutrophil flavocytochrome b with cytosolic proteins: transferred-NOESY NMR studies of a gp91phox C-terminal peptide bound to p47phox."
      Adams E.R. , Dratz E.A. , Gizachew D. , Deleo F.R. , Yu L. , Volpp B.D. , Vlases M. , Jesaitis A.J. , Quinn M.T.
      Biochem. J.325:249-257(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: STRUCTURE BY NMR OF 556-570 IN COMPLEX WITH NCF1;INTERACTION WITH NCF1
    14. 14.
      "A missense mutation in the neutrophil cytochrome b heavy chain in cytochrome-positive X-linked chronic granulomatous disease."
      Dinauer M.C. , Curnutte J.T. , Rosen H.R. , Orkin S.H.
      J. Clin. Invest.84:2012-2016(1989) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INVOLVEMENT IN CGD;VARIANT CGD HIS-415
    15. 15.
      "Point mutations in the beta-subunit of cytochrome b558 leading to X-linked chronic granulomatous disease."
      Bolscher B.G.J.M. , de Boer M. , de Klein A. , Weening R.S. , Roos D.
      Blood77:2482-2487(1991) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS CGD ARG-101; THR-156; TYR-209; SER-244 AND ALA-389
    16. 16.
      "A newly recognized point mutation in the cytochrome b558 heavy chain gene replacing alanine57 by glutamic acid, in a patient with cytochrome b positive X-linked chronic granulomatous disease."
      Ariga T. , Sakiyama Y. , Tomizawa K. , Imajoh-Ohmi S. , Kanegasaki S. , Matsumoto S.
      Eur. J. Pediatr.152:469-472(1993) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT CGD GLU-57
    17. 17.
      "Two novel point mutations in the cytochrome b 558 heavy chain gene, detected in two Japanese patients with X-linked chronic granulomatous disease."
      Ariga T. , Sakiyama Y. , Matsumoto S.
      Hum. Genet.94:441-441(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT CGD HIS-339
    18. 18.
      "A point mutation in gp91-phox of cytochrome b558 of the human NADPH oxidase leading to defective translocation of the cytosolic proteins p47-phox and p67-phox."
      Leusen J.H.W. , de Boer M. , Bolscher B.G.J.M. , Hilarius P.M. , Weening R.S. , Ochs H.D. , Roos D. , Verhoeven A.J.
      J. Clin. Invest.93:2120-2126(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT CGD GLY-500
    19. 19.
      "Identification of mutations in seven Chinese patients with X-linked chronic granulomatous disease."
      Hui Y.F. , Chan S.Y. , Lau Y.L.
      Blood88:4021-4028(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS CGD ILE-205; PHE-215 DEL AND GLN-342
    20. 20.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ERRATUM
    21. 21.
      "An in-frame triplet deletion within the gp91-phox gene in an adult X-linked chronic granulomatous disease patient with residual NADPH-oxidase activity."
      Jendrossek V. , Ritzel A. , Neubauer B. , Heyden S. , Gahr M.
      Eur. J. Haematol.58:78-85(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT CGD PHE-215 DEL
    22. 22.
      "X-linked chronic granulomatous disease: mutations in the CYBB gene encoding the gp91-phox component of respiratory-burst oxidase."
      Rae J. , Newburger P.E. , Dinauer M.C. , Noack D. , Hopkins P.J. , Kuruto R. , Curnutte J.T.
      Am. J. Hum. Genet.62:1320-1331(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS CGD ARG-20; SER-54; ARG-59; ARG-119; THR-156; GLN-209; ASN-222; ARG-222; TYR-222; LEU-223; ARG-244; LYS-309; LYS-315 DEL; GLU-322; PHE-325; PRO-333; HIS-339; PRO-356; ARG-405; GLU-408; ARG-408; HIS-415; LEU-415; PRO-422; ARG-453; CYS-516; ASP-534 AND ARG-537
    23. 23.
      "A novel mutation at a probable heme-binding ligand in neutrophil cytochrome b558 in atypical X-linked chronic granulomatous disease."
      Tsuda M. , Kaneda M. , Sakiyama T. , Inana I. , Owada M. , Kiryu C. , Shiraishi T. , Kakinuma K.
      Hum. Genet.103:377-381(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT CGD TYR-101
    24. 24.
      "Nicotinamide-adenine dinucleotide phosphate oxidase assembly and activation in EBV-transformed B lymphoblastoid cell lines of normal and chronic granulomatous disease patients."
      Dusi S. , Nadalini K.A. , Donini M. , Zentilin L. , Wientjes F.B. , Roos D. , Giacca M. , Rossi F.
      J. Immunol.161:4968-4974(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS CGD ARG-179 AND 298-THR--THR-302 DEL
    25. 25.
      "Genetic analysis of 13 families with X-linked chronic granulomatous disease reveals a low proportion of sporadic patients and a high proportion of sporadic carriers."
      Ariga T. , Furuta H. , Cho K. , Sakiyama Y.
      Pediatr. Res.44:85-92(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS CGD MET-54; ASP-55; GLU-57; HIS-339 AND PHE-344
    26. 26.
      "Uncommon missense and splice mutations and resulting biochemical phenotypes in German patients with X-linked chronic granulomatous disease."
      Roesler J. , Heyden S. , Burdelski M. , Schaefer H. , Kreth H.-W. , Lehmann R. , Paul D. , Marzahn J. , Gahr M. , Roesen-Wolff A.
      Exp. Hematol.27:505-511(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS CGD PHE-193; ARG-222; TYR-338; HIS-339 AND PRO-546;VARIANT ARG-364
    27. 27.
      "Molecular analysis of chronic granulomatous disease caused by defects in gp91-phox."
      Patino P.J. , Perez J.E. , Lopez J.A. , Condino-Neto A. , Grumach A.S. , Botero J.H. , Curnutte J.T. , Garcia de Olarte D.
      Hum. Mutat.13:29-37(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS CGD VAL-225 AND TYR-244
    28. 28.
      "Statistical and mutational analysis of chronic granulomatous disease in Japan with special reference to gp91-phox and p22-phox deficiency."
      Ishibashi F. , Nunoi H. , Endo F. , Matsuda I. , Kanegasaki S.
      Hum. Genet.106:473-481(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS CGD MET-54; ASP-55; GLU-57; TYR-101; ARG-209; GLY-224; LYS-309; TYR-338; HIS-339; PHE-344; GLU-389; PRO-420 AND ARG-516
    29. 29.
      "Characterization of 11 novel mutations in the X-linked chronic granulomatous disease (CYBB gene)."
      Gerard B. , El Benna J. , Alcain F. , Gougerot-Pocidalo M.-A. , Grandchamp B. , Chollet-Martin S.
      Hum. Mutat.18:163-163(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS CGD 54-ARG-ALA-55 DEL; TRP-59; PRO-307 AND ARG-505
    30. 30.
      "Molecular and functional characterization of a new X-linked chronic granulomatous disease variant (X91+) case with a double missense mutation in the cytosolic gp91phox C-terminal tail."
      Stasia M.J. , Lardy B. , Maturana A. , Rousseau P. , Martel C. , Bordigoni P. , Demaurex N. , Morel F.
      Biochim. Biophys. Acta1586:316-330(2002) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS CGD ASN-303 AND ARG-304
    31. 31.
      "Functional analysis of two-amino acid substitutions in gp91 phox in a patient with X-linked flavocytochrome b558-positive chronic granulomatous disease by means of transgenic PLB-985 cells."
      Bionda C. , Li X.J. , van Bruggen R. , Eppink M. , Roos D. , Morel F. , Stasia M.-J.
      Hum. Genet.115:418-427(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: CHARACTERIZATION OF VARIANTS CGD ASN-303 AND ARG-304
    32. 32.
      "First report of clinical, functional, and molecular investigation of chronic granulomatous disease in nine Jordanian families."
      Bakri F.G. , Martel C. , Khuri-Bulos N. , Mahafzah A. , El-Khateeb M.S. , Al-Wahadneh A.M. , Hayajneh W.A. , Hamamy H.A. , Maquet E. , Molin M. , Stasia M.J.
      J. Clin. Immunol.29:215-230(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT CGD ARG-408
    33. 33.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS IMD34 PRO-178 AND PRO-231
    34. 34.
      "Identification and functional characterization of two novel mutations in the alpha-helical loop (residues 484-503) of CYBB/gp91(phox) resulting in the rare X91(+) variant of chronic granulomatous disease."
      Boog B. , Quach A. , Costabile M. , Smart J. , Quinn P. , Singh H. , Gold M. , Booker G. , Choo S. , Hii C.S. , Ferrante A.
      Hum. Mutat.33:471-475(2012) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS CGD ASP-488 AND GLU-500
    35. 35.
      "Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients."
      Koeker M.Y. , Camcioglu Y. , van Leeuwen K. , Kilic S.S. , Barlan I. , Yilmaz M. , Metin A. , de Boer M. , Avcilar H. , Patiroglu T. , Yildiran A. , Yegin O. , Tezcan I. , Sanal O. , Roos D.
      J. Allergy Clin. Immunol.132:1156-1163(2013) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS CGD ASN-299; ASP-338; HIS-339; PHE-344 AND GLU-412
    Product Feedback Wall
    Hot Genes
    Atf2 ASPRO ACE ALCAM C19orf80 Trap1a Gdf5
    Top Searches
    Ubiquitin-protein ligase metalloproteinase Ubiquitin ELISA Alpha Tumor necrosis Asprosin TRAP1A
    Why choose EIAAB
    Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
    Further Information
    About us Protein center Bank account Distributors Terms & Conditions Career eiaab.com.cn

    Copyright & copy www.eiaab.com2006-2016 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

    鄂ICP备10015095号-1

    鄂公网安备 42018502005535号

    Twitter